SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMPs sharp rally and surge in trading volume are driving attention, with traders debating whether the move reflects accumulation and a lasting breakout or another short-lived pump. Bullish posts point to Flexas European expansion and broader crypto-payments adoption, while skeptics say meaningful usage and sustained demand remain unproven.

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

A reported partnership with The Clearing House to support interoperability for tokenized bank deposits is driving attention, with traders tying it to Quants role in financial infrastructure and upcoming Sibos discussion. Bulls also point to QNTs limited supply as fuel for the rally, while skeptics question whether institutional adoption will translate into lasting token demand.

VeChain is a public Layer-1 blockchain designed for real-world applications. Founded in 2015, its VeChainThor network supports enterprise and consumer use cases involving supply chains, product provenance, sustainability, digital product passports, tokenized incentives and verifiable data.  VeChainThor combines EVM-compatible smart contracts with a dual-token model, native fee delegation and multi-clause transactions. VET is the network’s native asset and staking collateral, while VTHO is used to pay transaction fees and execute smart contracts.  VeChain’s ecosystem includes VeBetter, an app platform that rewards verified positive actions; StarGate, its NFT-based staking platform; VeWorld, its self-custody wallet; and VeWorld.ai, its AI-agent platform. In its April 2026 roadmap, VeChain reported that VeBetter had reached 5.3 million users, more than 50 live applications and over 50 million verified actions.  VeChain has also worked with organizations including Walmart China, DNV, PwC, Boston Consulting Group and UFC across enterprise, sustainability and consumer initiatives.

Vechain

VETs rebound and breakout attempt are drawing attention, with traders focused on whether it can reclaim the penny threshold after a prolonged decline. Bulls point to network upgrades and ecosystem development as potential support, while skeptics question whether the price strength can last.

|The Artificial Superintelligence (ASI) Alliance is the world’s largest open-source initiative dedicated to decentralized Artificial General Intelligence (AGI). Formed in April 2024, the ASI Alliance unites SingularityNET, Fetch.ai, and Ocean Protocol, with CUDOS joining as a network member shortly after. The ASI Alliance was established through a community-approved tokenomic merger—combining $AGIX, $FET, and $OCEAN into a single token: $FET. This unified token underpins a collaborative framework designed to scale open-source AI and stand as the largest open-sourced, independent entity in AI research and development. The Alliance is committed to accelerating the advancement of decentralized Artificial General Intelligence (AGI) and, ultimately, Artificial Superintelligence (ASI). It provides a robust, open-source innovation stack, empowering developers, enterprises, and researchers globally to build ethical, scalable, and groundbreaking AI solutions. This ensures that advanced intelligence remains a shared, accessible resource, fostering innovation beyond centralized systems and promoting a future where AI benefits all.

Fetch.ai

FETs rebound is drawing attention amid renewed interest in AI-focused crypto and autonomous-agent projects, with traders pointing to Fetch/ASI product activity and its planned agent infrastructure as reasons for optimism. The move has prompted breakout and accumulation talk, but skeptics question whether the rally can hold, citing Bitcoins influence, resistance levels, and uncertainty about real-world adoption.

XYO is the cryptographic proof layer for the real world, collecting, validating, and delivering physical-world data to AI, robotics, Web3, and enterprise systems. XYO, the original Decentralized Physical Infrastructure Network (DePIN), has been operating since 2018 and now has more than 10 million nodes worldwide.   At the core of XYO is XYO Layer One, a scalable data blockchain built to support high-volume data industries such as AI, robotics, location intelligence, and real-world asset (RWA) systems. Designed for high throughput and low transaction costs, it gives these data-intensive applications the capacity to process and validate information across massive datasets. XYO Layer One anchors XYO's Proof of Location and Proof of Origin technologies, establishing a verified origin, precise timing, and trusted source behind every piece of data. This verified data directly feeds the XYO AI SDK, a product built by XYO to provide accessibility for developers to build AI-powered applications, autonomous agents, robotics integrations and more using real-world data.  XYO employs a unique dual-token model:  XYO Token: An externally traded token supporting the DePIN ecosystem, rewards, staking, and governance, enhancing overall ecosystem value and scarcity.   XL1 Token: Internal to the XYO Layer One blockchain, facilitating transactions, gas fees, and other blockchain-specific use cases.  The dual-token economics are strategically designed to increase scarcity and promote sustainable growth.   The XYO token has been available on major exchanges since 2018. Major exchanges include Coinbase and Revolut. The XL1 token is now also available.

XYO Network

A modest rebound has traders watching whether XYO can clear the 200-day moving average and hold above resistance; bulls anticipate a breakout, while skeptics argue that rallies repeatedly fade and call the token a pump-and-dump.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiaks scheduled DAYBREAK Phase 3 topline readout for its wet AMD candidates, Zenkuda and KSI-501, is driving attention. Traders are debating the binary trial risk, with some positioning for a strong result and others selling or shorting amid uncertainty and pre-readout volatility.

Bonk is a dog-themed memecoin on the Solana blockchain, launched on Christmas Day 2022 to revitalize the Solana community following the FTX collapse. Created by an anonymous team of 22 Solana developers and builders, Bonk distributed 50% of its total 100 trillion token supply via airdrop to community members including NFT collectors, developers, and artists.   The project positions itself as "the first Solana dog coin for the people, by the people," explicitly rejecting venture capital backing in favor of grassroots community ownership. What sets Bonk apart from other memecoins is its combination of fair launch mechanics, extensive ecosystem integration, and active deflationary strategy.   Built on Solana, BONK benefits from fast transaction speeds and low fees that make it practical for everyday use. Native products include LetsBonk.fun (a memecoin launchpad that briefly became Solana's market leader in 2025, surpassing Pump.fun with over 78% market share), BonkSwap (a decentralized exchange) and BonkBot (a Telegram trading bot with built-in burn mechanics).   BONK is available across 10 blockchain networks and listed on major exchanges including Binance, Coinbase, Kraken, and Robinhood. Governance is handled by BonkDAO, which holds 15% of the token supply and makes decisions through on-chain voting.   The community has organized several major burn events, most notably the December 2024 BURNmas campaign that destroyed 1.69 trillion tokens worth over $50 million. In September 2025, Nasdaq-listed Safety Shot, Inc. formed BONK Holdings LLC and acquired over 2.5% of the circulating supply (valued at $55-63 million), making BONK one of the first memecoins to attract formal corporate treasury adoption. Core contributor Nom was appointed to Safety Shot's board, and the company holds a 10% revenue share in LetsBonk.fun.  As with all memecoins, BONK is a highly speculative asset with substantial volatility. Its value is primarily driven by community sentiment, social media momentum, and meme culture rather than traditional utility.   The anonymous team, while common in the memecoin space, means investors should exercise appropriate caution. Despite these risks, Bonk has established itself as one of the most successful community-driven tokens in the Solana ecosystem, approaching 1 million unique holders and expanding from a simple memecoin into meaningful DeFi infrastructure.

BONK

Claims of a BONK DAO exploit involving stolen tokens, alongside concern about an Upbit delisting, dominate the discussion. Traders debate whether the resulting weakness is a dip-buying opportunity or a sign of deeper security and trust problems.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GM is drawing attention for a technical bounce and bullish breakout setups, with traders pointing to recent strength and the stock holding key chart levels. The optimism, supported by earlier earnings and guidance upgrades, is tempered by concerns about vehicle sales, limited hybrid offerings, tariffs, and competition from Chinese automakers.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Renewed LUNC comeback speculation centers on token burns, an anticipated Market Module 2.0 upgrade and a possible USTC repeg, with traders also pointing to Terra ecosystem activity. Bulls see these as potential supply-reduction and recovery catalysts, while skeptics question whether burns and weak trading volume can overcome the large supply and repeated failed rallies.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

FDA approval of Revolution Medicines Rasonque (daraxonrasib) for metastatic pancreatic cancer is the dominant catalyst, with traders focused on the treatments clinical impact and the companys commercial opportunity. The community is bullish on the approval and pipeline, but some question the muted post-approval share reaction and whether launch prospects are already reflected in the valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

IFF Launches Omni-Bos PHY to Help Dairy Producers Get More Value from Feed

IFF (NYSE: IFF) a global leader in flavors, fragrances and health and biosciences today announced the launch of Omni-Bos PHY, a novel phytase enzyme designed specifically for dairy cattle. The technology helps producers improve nutrient utilization and feed efficiency by unlocking nutrients already...

Orion (OEC) Down 21.5% Since Last Earnings Report: Can It Rebound?

Orion (OEC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

International Flavors (IFF) Down 1.3% Since Last Earnings Report: Can It Rebound?

International Flavors (IFF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

IFF Report Finds GLP-1 Is Reshaping Food Choices and Eating Behaviors Among Indian Consumers

IFF (NYSE: IFF) a global leader in flavors, fragrances and health and biosciences released new research examining how GLP-1 use is influencing food behaviors among Indian consumers and what those shifts may mean for the future of food and beverage innovation. The study is the latest in IFFs GLP-1...

IFF to Webcast Fireside Chat at Barclays Global Consumer Conference on Sept. 10

IFF (NYSE: IFF) today announced that Chief Executive Officer Erik Fyrwald will participate in a fireside chat at the Barclays Global Consumer Conference on Thursday, Sept. 10, 2026 at 945 a.m. ET. Investors may access the live webcast on the Company's website at ir.iff.com. For those unable to...

Don't Overlook International Flavors (IFF) International Revenue Trends While Assessing the Stock

Explore International Flavors' (IFF) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

AbbVie Takes Over #60 Spot From International Flavors & Fragrances

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, AbbVie Inc (Symbol: ABBV) has taken over the #60 spot from International Flavors & Fragrances Inc. (Symbol: IFF), according to ETF Channel. Below is a chart of A...

International Flavors Q2 Earnings Miss Estimates, Sales Rise Y/Y

IFF misses Q2 earnings estimates as sales rise y/y, while portfolio changes, growth across key segments and a new buyback shape its outlook.

International Flavors (IFF) Misses Q2 Earnings and Revenue Estimates

International Flavors (IFF) delivered earnings and revenue surprises of -28.07% and -27.16%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

International Flavors (IFF) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for International Flavors (IFF) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B's Food & Beverage division and the food protection business of N&B's Health & Biosciences division. The Health & Biosciences business consists of a biotechnology-driven portfolio of enzymes, food cultures, probiotics and specialty ingredients for food, home and personal care, and health and wellness applications. The Scent business creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world’s finest perfumes and best-known household and personal care products. The Pharma Solutions business produces a vast portfolio including cellulosics and seaweed-based pharma excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling. The company was founded in 1833 and is headquartered in New York, NY.

International Flavors & Fragrances Inc.

Bullish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$85.69
Prev Close	$85.85
Open	$86.33
Dividend Yield	2.37%
50-Day Moving Average	$83.19
Beta	0.69
Avg. Volume	1.56M
PE Ratio	79.50

52-Week High	$89.32
52-Week Low	$59.14
Market Capitalization	$21.86B
EPS (Annual)	-$1.41
Price to Book	1.57
Revenue Per Employee	$506,511.63

Feed

News

Sentiment

Earnings

Fundamentals

Info

IFF Fundamentals